Acadia Healthcare (NASDAQ:ACHC) Price Target Cut to $37.00 by Analysts at Mizuho

Acadia Healthcare (NASDAQ:ACHC) had its price objective decreased by stock analysts at Mizuho from $48.00 to $37.00 in a report issued on Tuesday,Benzinga reports. The firm currently has a “neutral” rating on the stock. Mizuho’s price objective would indicate a potential upside of 27.85% from the stock’s current price.

Other research analysts have also issued research reports about the company. Cantor Fitzgerald reiterated a “neutral” rating and set a $52.00 price target on shares of Acadia Healthcare in a research report on Tuesday, December 10th. Royal Bank of Canada reduced their price objective on shares of Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating for the company in a report on Monday, March 3rd. StockNews.com cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, January 6th. Barclays lowered shares of Acadia Healthcare from an “overweight” rating to an “equal weight” rating and reduced their price target for the stock from $43.00 to $35.00 in a research note on Friday, February 28th. Finally, Bank of America dropped their target price on Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating on the stock in a report on Friday, February 28th. One analyst has rated the stock with a sell rating, three have issued a hold rating and five have assigned a buy rating to the stock. According to MarketBeat, Acadia Healthcare has a consensus rating of “Hold” and a consensus price target of $52.19.

Acadia Healthcare Price Performance

Shares of NASDAQ:ACHC opened at $28.94 on Tuesday. The firm’s 50 day moving average is $38.23 and its two-hundred day moving average is $46.15. The firm has a market capitalization of $2.69 billion, a P/E ratio of 9.49, a PEG ratio of 1.46 and a beta of 1.38. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare has a 52 week low of $27.61 and a 52 week high of $82.41.

Hedge Funds Weigh In On Acadia Healthcare

A number of institutional investors have recently modified their holdings of ACHC. Charles Schwab Investment Management Inc. raised its holdings in Acadia Healthcare by 2.7% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,127,061 shares of the company’s stock worth $71,467,000 after acquiring an additional 29,936 shares during the period. Cerity Partners LLC lifted its position in shares of Acadia Healthcare by 43.7% during the 3rd quarter. Cerity Partners LLC now owns 32,922 shares of the company’s stock worth $2,088,000 after purchasing an additional 10,019 shares during the last quarter. Dynamic Technology Lab Private Ltd bought a new stake in Acadia Healthcare during the 3rd quarter valued at approximately $458,000. Bank of Montreal Can increased its position in Acadia Healthcare by 2,456.1% in the 3rd quarter. Bank of Montreal Can now owns 324,569 shares of the company’s stock worth $20,539,000 after buying an additional 311,871 shares during the period. Finally, BNP Paribas Financial Markets lifted its holdings in shares of Acadia Healthcare by 1,601.3% during the third quarter. BNP Paribas Financial Markets now owns 281,220 shares of the company’s stock worth $17,832,000 after buying an additional 264,690 shares during the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.